Literature DB >> 23123458

Role of arsenic (+3 oxidation state) methyltransferase in arsenic metabolism and toxicity.

Daigo Sumi1, Seiichiro Himeno.   

Abstract

The metabolism of arsenicals, including their reduction and methylation has been extensively studied, and both classical and novel pathways of arsenic methylation are proposed. Arsenic methylation has been considered to be a detoxification process of inorganic arsenicals, although recent studies have indicated that trivalent methylated arsenicals, the intermediate products of arsenic methylation, are more toxic than inorganic arsenicals. In 2002, arsenite (+3 oxidation state) methyltransferase (As3MT) was discovered to be an enzyme responsible for arsenic methylation. This review focuses on current information on the function, genetic polymorphism, and alternative splicing of As3MT, all of which contribute to arsenic metabolism and toxicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123458     DOI: 10.1248/bpb.b212015

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

Review 1.  Molecular insight of arsenic-induced carcinogenesis and its prevention.

Authors:  Paramita Mandal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-22       Impact factor: 3.000

2.  An interaction of inorganic arsenic exposure with body weight and composition on type 2 diabetes indicators in Diversity Outbred mice.

Authors:  James G Xenakis; Christelle Douillet; Timothy A Bell; Pablo Hock; Joseph Farrington; Tianyi Liu; Caroline E Y Murphy; Avani Saraswatula; Ginger D Shaw; Gustavo Nativio; Qing Shi; Abhishek Venkatratnam; Fei Zou; Rebecca C Fry; Miroslav Stýblo; Fernando Pardo-Manuel de Villena
Journal:  Mamm Genome       Date:  2022-07-11       Impact factor: 3.224

3.  RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice.

Authors:  Hong Lu; Sumedha Gunewardena; Julia Y Cui; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-02-04       Impact factor: 3.922

4.  Arsenic 3 methyltransferase (AS3MT) automethylates on cysteine residues in vitro.

Authors:  Sofiane Y Mersaoui; Cynthia Guilbert; Hsiang Chou; Christelle Douillet; D Scott Bohle; Miroslav Stýblo; Stéphane Richard; Koren K Mann
Journal:  Arch Toxicol       Date:  2022-03-04       Impact factor: 6.168

5.  Genetic variation in arsenic (+3 oxidation state) methyltransferase (AS3MT), arsenic metabolism and risk of basal cell carcinoma in a European population.

Authors:  Karin S Engström; Marie Vahter; Tony Fletcher; Giovanni Leonardi; Walter Goessler; Eugen Gurzau; Kvetoslava Koppova; Peter Rudnai; Rajiv Kumar; Karin Broberg
Journal:  Environ Mol Mutagen       Date:  2014-08-25       Impact factor: 3.216

6.  Ataxia telangiectasia and rad3 related (ATR)-promyelocytic leukemia protein (PML) pathway of the DNA damage response in the brain of rats administered arsenic trioxide.

Authors:  Ryo Watanabe; Kana Unuma; Kanako Noritake; Takeshi Funakoshi; Toshihiko Aki; Koichi Uemura
Journal:  J Toxicol Pathol       Date:  2017-07-03       Impact factor: 1.628

Review 7.  Recent population genomic insights into the genetic basis of arsenic tolerance in humans: the difficulties of identifying positively selected loci in strongly bottlenecked populations.

Authors:  Mario Apata; Susanne P Pfeifer
Journal:  Heredity (Edinb)       Date:  2019-11-27       Impact factor: 3.821

8.  The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.

Authors:  Enrico D'Ambrosio; Tarik Dahoun; Antonio F Pardiñas; Mattia Veronese; Michael A P Bloomfield; Sameer Jauhar; Ilaria Bonoldi; Maria Rogdaki; Sean Froudist-Walsh; James T R Walters; Oliver D Howes
Journal:  Psychiatry Res Neuroimaging       Date:  2019-07-19       Impact factor: 2.376

9.  Genome-wide significant schizophrenia risk variation on chromosome 10q24 is associated with altered cis-regulation of BORCS7, AS3MT, and NT5C2 in the human brain.

Authors:  Rodrigo R R Duarte; Claire Troakes; Matthew Nolan; Deepak P Srivastava; Robin M Murray; Nicholas J Bray
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-03-22       Impact factor: 3.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.